Position in ADCT
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$44,081
+$1,368 QoQ
Shares Held
11,755
-2.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ethic Inc. holds $17,529,957 across 9 Drug Manufacturers - Specialty & Generic names. ADCT ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
334,836 | $6,201,162 | |
| 2 | ZTS |
Zoetis Inc.
|
38,751 | $4,580,755 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
120,027 | $1,662,373 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
64,231 | $1,537,047 | |
| 5 | VTRS |
Viatris Inc
|
90,477 | $1,222,344 | |
| 6 | HLN |
Haleon plc
|
105,141 | $1,052,461 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,078 | $639,232 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,605 | $590,502 |
All Filings in ADCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,081 | 11,755 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $42,713 | 12,100 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $60,828 | 15,207 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $101,470 | 37,862 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||